Elkhorn Partners’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,500
| Closed | -$104K | – | 42 |
|
|
2024
Q4 | $104K | Buy |
2,500
+300
| +14% | +$12.5K | 0.07% | 28 |
|
|
2024
Q3 | $147K | Buy |
+2,200
| New | +$147K | 0.09% | 22 |
|
|
2024
Q1 | – | Sell |
-550
| Closed | -$55K | – | 48 |
|
|
2023
Q4 | $55K | Sell |
550
-630
| -53% | -$63K | 0.04% | 37 |
|
|
2023
Q3 | $122K | Buy |
1,180
+880
| +293% | +$91K | 0.08% | 28 |
|
|
2023
Q2 | $36K | Buy |
+300
| New | +$36K | 0.02% | 43 |
|
|
2021
Q2 | – | Sell |
-300
| Closed | -$39K | – | 51 |
|
|
2021
Q1 | $39K | Buy |
+300
| New | +$39K | 0.02% | 33 |
|